newsfilter
← Latest News
PR Newswire·

Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI

Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical ...